Annual Operating Profit
-$54.12 M
+$10.94 M+16.81%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual operaing income is currently -$54.12 million, with the most recent change of +$10.94 million (+16.81%) on 31 December 2023. MLTX annual operating profit is now at all-time high.MLTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$43.11 M
-$12.53 M-40.99%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly operating income is currently -$43.11 million, with the most recent change of -$12.53 million (-40.99%) on 30 September 2024. Over the past year, it has dropped by -$30.14 million (-232.23%). MLTX quarterly operating profit is now -587.90% below its all-time high of -$6.27 million, reached on 30 September 2021.MLTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$108.54 M
-$30.14 M-38.44%
30 September 2024
Summary:
MoonLake Immunotherapeutics TTM operating income is currently -$108.54 million, with the most recent change of -$30.14 million (-38.44%) on 30 September 2024. Over the past year, it has dropped by -$52.75 million (-94.55%). MLTX TTM operating profit is now -232.11% below its all-time high of -$32.68 million, reached on 30 June 2021.MLTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | -232.2% | -94.5% |
| 3 y3 years | - | -587.9% | -178.7% |
| 5 y5 years | - | - | - |
MLTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +16.8% | -587.9% | at low | -178.7% | at low |
| 5 y | 5 years | at high | +16.8% | -587.9% | at low | -232.1% | at low |
| alltime | all time | at high | +16.8% | -587.9% | at low | -232.1% | at low |
MoonLake Immunotherapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$43.11 M(+41.0%) | -$108.54 M(+38.4%) |
| June 2024 | - | -$30.58 M(+54.3%) | -$78.40 M(+28.5%) |
| Mar 2024 | - | -$19.82 M(+31.9%) | -$61.01 M(+12.7%) |
| Dec 2023 | -$54.12 M | -$15.03 M(+15.8%) | -$54.12 M(-3.0%) |
| Sept 2023 | - | -$12.98 M(-1.6%) | -$55.79 M(-3.1%) |
| June 2023 | - | -$13.19 M(+2.0%) | -$57.58 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.93 M(-22.5%) | -$62.05 M(-4.6%) |
| Dec 2022 | -$65.06 M | -$16.70 M(+13.0%) | -$65.06 M(+34.5%) |
| Sept 2022 | - | -$14.77 M(-16.3%) | -$48.37 M(+21.3%) |
| June 2022 | - | -$17.65 M(+10.7%) | -$39.86 M(-27.4%) |
| Mar 2022 | - | -$15.94 M(+154.4%) | -$54.89 M(+40.9%) |
| Sept 2021 | - | -$6.27 M(-80.8%) | -$38.95 M(+19.2%) |
| June 2021 | - | -$32.68 M | -$32.68 M |
FAQ
- What is MoonLake Immunotherapeutics annual operaing income?
- What is the all time high annual operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual operating profit year-on-year change?
- What is MoonLake Immunotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly operating profit year-on-year change?
- What is MoonLake Immunotherapeutics TTM operating income?
- What is the all time high TTM operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM operating profit year-on-year change?
What is MoonLake Immunotherapeutics annual operaing income?
The current annual operating profit of MLTX is -$54.12 M
What is the all time high annual operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual operaing income is -$54.12 M
What is MoonLake Immunotherapeutics annual operating profit year-on-year change?
Over the past year, MLTX annual operaing income has changed by +$10.94 M (+16.81%)
What is MoonLake Immunotherapeutics quarterly operating income?
The current quarterly operating profit of MLTX is -$43.11 M
What is the all time high quarterly operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly operating income is -$6.27 M
What is MoonLake Immunotherapeutics quarterly operating profit year-on-year change?
Over the past year, MLTX quarterly operating income has changed by -$30.14 M (-232.23%)
What is MoonLake Immunotherapeutics TTM operating income?
The current TTM operating profit of MLTX is -$108.54 M
What is the all time high TTM operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM operating income is -$32.68 M
What is MoonLake Immunotherapeutics TTM operating profit year-on-year change?
Over the past year, MLTX TTM operating income has changed by -$52.75 M (-94.55%)